Issue Date | Title | Involved Person(s) |
17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
2021 | Latrogenic effects of the FDA black box warning on antidepressants – signal or noise? | Plöderl, Martin; Hengartner, Michael P. |
2021 | Maintenance therapy with antidepressants : prophylactic effects or withdrawal reactions? | Plöderl, Martin; Hengartner, Michael P. |
2021 | Suicide risk with selective serotonin reuptake inhibitors and other new-generation serotonergic-noradrenergic antidepressants in adults : a meta-analysis of observational studies | Hengartner, Michael P.; Plöderl, Martin; Amendola, Simone; Kindler, Simone; Bschor, Tom, et al |
25-Nov-2020 | Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
2020 | Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials | Hengartner, Michael Pascal; Jakobsen, Janus C.; Sørensen, Anders; Plöderl, Martin |
2020 | Commentary to “antidepressants and suicidality : a re-analysis of the re-analysis” | Plöderl, Martin; Hengartner, Michael Pascal; Bschor, Tom; Kaminski, Jakob André |